| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bb3a52fede77711d08747cbe80c826
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_054fde23694a25b21fadd301437e7d95
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9371ddb12d313ca1a25432222afa8f9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-209
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-485
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-167
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-22 |
| filingDate |
2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ebcc7971cd24a3353d2e33b283519bed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e0fffcfefa18cdfa2b59f70ffd80821 |
| publicationDate |
2014-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-8765178-B2 |
| titleOfInvention |
Controlled release formulations and associated methods |
| abstract |
A pharmaceutical formulation having a geometric configuration that affects the release characteristics of active agents contained therein and associated methods are provided. In one aspect, a sustained release oral dosage pharmaceutical tablet may include a first layer having a first active agent, where the first layer is disposed between two adjacent controlled release layers, at least one of the adjacent layers including at least one second active agent. The two adjacent layers are arranged such that they cover a portion of the first layer. The two adjacent layers may be separate layers or they may be joined into a single continuous layer, depending on the overall configuration and geometric design of the oral dosage form. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9642809-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11400065-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583510-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11779557-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11723918-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11065224-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9005660-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11504347-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9023394-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9827199-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9358295-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9216176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11766418-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602513-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11602512-B1 |
| priorityDate |
2006-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |